| 2015-05 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial |
Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024. |
 |
| 2015-04-13 |
Association of dialysis with the risks of cancers |
PLoS ONE. 2015 Apr 13;10(4):Article number e0122856. |
|
| 2015-04 |
Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide |
Hepatology International. 2015 Apr;9(2):258-268. |
|
| 2015-04 |
The potent activation of Ca2+-activated K+ current by NVP-AUY922 in the human pancreatic duct cell line (PANC-1) possibly independent of heat shock protein 90 inhibition |
Journal of Pharmacological Sciences. 2015 Apr;127(4):404-413. |
|
| 2015-03 |
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients |
Cancer Chemotherapy and Pharmacology. 2015 Mar;75(3):579-586. |
|
| 2015-03 |
Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1 |
Oncotarget. 2015 Mar;6(9):6684-6707. |
|
| 2015-01 |
Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy |
Journal of Clinical Oncology. 2015 Jan;33(3, Suppl. ):234. |
|
| 2014-12-01 |
AMACR amplification in myxofibrosarcomas: A mechanism of overexpression that promotes cell proliferation with therapeutic relevance |
Clinical Cancer Research. 2014 Dec 01;20(23):6141-6152. |
|
| 2014-12 |
Pegylated arginine deiminase (ADI-PEG20) in relapsed/refractory and/or elder Acute Myeloid Leukemia: The preliminary result of phase II trial |
Blood. 2014 Dec;124(21):984. |
|
| 2014-11-30 |
MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors |
Oncotarget. 2014 Nov 30;5(22):11723-11736. |
|
| 2014-11 |
Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance |
Oncotarget. 2014 Nov 30;5(22):11428-11441. |
|
| 2014-10-18 |
AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: A driver of cell proliferation indicating adverse prognosis |
Oncotarget. 2014 Oct 18;5(22):11551-11566. |
|
| 2014-10-10 |
Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma |
Blood Cancer Journal. 2014 Oct 10;4:Article number eXX. |
|
| 2014-10 |
Stimulation of electroporation-induced inward currents in glioblastoma cell lines by the heat shock protein inhibitor AUY922 |
Clinical and Experimental Pharmacology and Physiology. 2014 Oct;41(10):830-837. |
|
| 2014-10 |
Nuclear expression of BCL10 has a role in the regulation of cell growth and progression of pancreatic cancer through the activation of NF-kappa B-related signaling |
Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 4217. |
|
| 2014-09 |
High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells |
European Journal of Pharmacology. 2014 Sep;738:332-341. |
|
| 2014-09 |
Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus |
Clinical Colorectal Cancer. 2014 Sep;13(3):145-155. |
|
| 2014-07-02 |
Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib the EVOLVE-1 randomized clinical trial |
JAMA. 2014 Jul 2;312(1):57-67. |
|
| 2014-07 |
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer |
Oncology. 2014 Jul;87(2):104-113. |
|
| 2014-06-20 |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity |
Blood Cancer Journal. 2014 Jun 20;4:Article number e220. |
|
| 2014-05 |
Using chinese herbal medicine containing mu-tong is associated with upper urinary tract cancer in patient with end-stage renal disease |
Nephrology, Dialysis, Transplantation. 2014 May;29(Suppl. 3):iii65-iii67. |
|
| 2014-05 |
Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad |
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):TPS4148. |
|
| 2014-05 |
Association of helicobacter pylori CagA translocation with the expression of CagA-signaling transduction molecules in gastric mucosa-associated lymphoid tissue lymphoma |
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):8571. |
|
| 2014-05 |
High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients |
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522. |
|
| 2014-05 |
A phase I dose escalation study of weekly BI 836845, a fully human, affinity-optineized, insulin -like growth factor (IGF) ligand neutralizing antibody, in patients with advanced solid cancers |
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):2617. |
|
| 2014-03 |
Overexpression of CDC28 protein kinase regulatory subunit 1B confers an independent prognostic factor in nasopharyngeal carcinoma |
APMIS. 2014 Mar;122(3):206-214. |
|
| 2014-02 |
RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated notch1 activation |
Journal of Cellular Physiology. 2014 Feb;229(2):191-201. |
|
| 2014-02 |
BCL6 overexpression is associated with decreased p19ARF expression and confers an independent prognosticator in gallbladder carcinoma |
Tumor Biology. 2014 Feb;35(2):1417-1426. |
|
| 2014-02 |
Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse |
Genes Chromosomes and Cancer. 2014 Feb;53(2):211-213. |
|
| 2014-02 |
The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: A nation-wide cancer registry-based study |
BMC Cancer. 2014 Feb 18;14:Article number 102. |
|
| 2014-01 |
EVOLVE-1: Phase 3 study of everolimus for advanced HCC that progressed during or after sorafenib |
Journal of Clinical Oncology. 2014 Jan;32(3 Suppl.):Abstract number 172 |
|
| 2014-01 |
Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial |
Journal of Clinical Oncology. 2014 Jan;32(3 Suppl):Abstract number 267. |
|
| 2013-12-31 |
Second cancers in patients with neuroendocrine tumors |
PLoS ONE. 2013 Dec 31;8(12):Article number e86414. |
|
| 2013-12 |
Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma |
Tumor Biology. 2013 Dec;34(6):3923-3931. |
|
| 2013-12 |
Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma |
Journal of Hepatology. 2013 Dec;59(6):1271-1277. |
|
| 2013-12 |
Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient |
Kaohsiung Journal of Medical Sciences. 2013 Dec;29(12):691-694. |
|
| 2013-11 |
A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression |
Gastroenterology. 2013 Nov;145(5):1110-1120. |
|
| 2013-11 |
Management of gastric cancer in Asia: Resource-stratified guidelines |
Lancet Oncology. 2013 Nov;14(12):e535-e547. |
|
| 2013-10 |
Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification |
Biochemical Pharmacology. 2013 Oct;86(7):872-887. |
|
| 2013-10 |
Clinicopathological significance of HuR expression in gallbladder carcinoma: With special emphasis on the implications of its nuclear and cytoplasmic expression |
Tumor Biology. 2013 Oct;34(5):3059-3069. |
|
| 2013-08 |
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer |
British Journal of Cancer. 2013 Aug;109(4):920-925. |
|
| 2013-07-23 |
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder |
Journal of Clinical Pathology. 2013 Jul 23;66(7):573-582. |
|
| 2013-07-22 |
Medical risk factors associated with cholangiocarcinoma in taiwan: A population-based case-control study |
PLoS ONE. 2013 Jul 22;8(7):Article number e69981. |
|
| 2013-07 |
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance |
Blood Cancer Journal. 2013 Jul;3:Article number e125. |
|
| 2013-06-21 |
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma |
Annals of Oncology. 2013 Jun 21;24(6):1567-1573. |
|
| 2013-06-20 |
Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations |
PLoS ONE. 2013 Jun 20;8(6):Article number e65762. |
|
| 2013-06 |
No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply |
Genes Chromosomes and Cancer. 2013 Jun;52(6):593-594. |
|
| 2013-06 |
ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: Aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance |
Clinical Cancer Research. 2013 Jun;19:2861-2872. |
|
| 2013-05 |
Loss of epithelial membrane protein-2 expression confers an independent prognosticator in gallbladder carcinoma |
Biomarkers and Genomic Medicine. 2013 May;5(1-2):31-38. |
|
| 2013-05 |
E2F transcription factor 1 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinomas |
Biomarkers and Genomic Medicine. 2013 May;5(1-2):23-30. |
|
